US SC to decide on access to mifepristone: What's at stake and what could happen next

At issue is the availability of mifepristone, part of a two-drug regimen that now accounts for more than half of the abortions in the United States. More than 5 million women have used mifepristone to terminate their pregnancies in the United States, and dozens of other countries have approved the drug for use

Related Keywords

United States ,Texas ,Washington ,Amarillo ,New Mexico ,District Of Columbia ,Justice Samuel Alito ,Thomas Rice ,Matthew Kacsmaryk ,Santa Teresa ,Drug Administration ,Us District Court ,Us Supreme Court ,Reuters ,Us Circuit Court ,Supreme Court ,Samuel Alito ,New Orleans ,Reproductive Clinic ,Northern District ,Judge Thomas Rice ,Eastern District ,Mifepristone Supreme Court ,S Mifepristone The Morning After Pill ,Planned Parenthood ,Mifepristone Fda Approval ,Acsmaryk Mifepristone Ruling ,Abortion Drug Ruling ,Judge Kacsmaryk ,Ifepristone Manufacturer ,Danco Laboratories ,Th Circuit Mifepristone ,Fifth Circuit Mifepristone ,Ow To Pronounce Mifepristone ,Ho Makes Mifepristone ,Ho Manufactures Mifepristone ,Ifepristone Wiki ,Abortion Pill Ruling ,Exas Judge Mifepristone ,Mifepristone Safety ,Buy Mifepristone ,Isoprostol Vs Mifepristone ,Mifepristone Decision ,Texas Mifepristone Ruling ,Ow Does Mifepristone Work In The Body , ,